Chemotherapy-induced hair loss is widely recognised as one of the most traumatic side effects associated with cancer treatment, and yet it is still one of the least explored. We are changing that.

Paxman has been pioneering scalp cooling technology for over a quarter of a century. Our clinically proven cold cap system has helped over 100,000 cancer patients in more than 25 countries worldwide to retain their hair during chemotherapy.

The Paxman Scalp Cooling System is now FDA cleared. As part of the clearance process the system was used in the first-ever randomized clinical trial to evaluate modern scalp cooling. Read More

Please note that Paxman will be closed on 24th, 25th and 26th December 2018 and 1st January 2019